Wu W - Search Results

1

High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.

Bai S, Chen T, Du T, Chen X, Lai Y, Ma X, Wu W, Lin C, Liu L, Huang H. Bai S, et al. Among authors: wu w. Oncol Lett. 2017 Dec;14(6):6801-6808. doi: 10.3892/ol.2017.7027. Epub 2017 Sep 22. Oncol Lett. 2017. PMID: 29163701 Free PMC article.

2

Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.

Guo Z, Chen X, Du T, Zhu D, Lai Y, Dong W, Wu W, Lin C, Liu L, Huang H. Guo Z, et al. Among authors: wu w. Med Oncol. 2017 Jan;34(1):13. doi: 10.1007/s12032-016-0872-3. Epub 2016 Dec 23. Med Oncol. 2017. PMID: 28012134

3

Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B.

Huang H, Wang Q, Du T, Lin C, Lai Y, Zhu D, Wu W, Ma X, Bai S, Li Z, Liu L, Li Q. Huang H, et al. Among authors: wu w. Prostate. 2018 Apr;78(5):327-335. doi: 10.1002/pros.23469. Epub 2018 Jan 21. Prostate. 2018. PMID: 29356020

4

Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.

Peng S, Du T, Wu W, Chen X, Lai Y, Zhu D, Wang Q, Ma X, Lin C, Li Z, Guo Z, Huang H. Peng S, et al. Among authors: wu w. Urol Oncol. 2018 Aug;36(8):366.e1-366.e9. doi: 10.1016/j.urolonc.2018.05.021. Epub 2018 Jun 19. Urol Oncol. 2018. PMID: 29903461

5

High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.

Ma X, Du T, Zhu D, Chen X, Lai Y, Wu W, Wang Q, Lin C, Li Z, Liu L, Huang H. Ma X, et al. Among authors: wu w. Oncol Lett. 2018 Nov;16(5):6749-6755. doi: 10.3892/ol.2018.9490. Epub 2018 Sep 24. Oncol Lett. 2018. PMID: 30405818 Free PMC article.

6

Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.

Lin C, Bai S, Du T, Lai Y, Chen X, Peng S, Ma X, Wu W, Guo Z, Huang H. Lin C, et al. Among authors: wu w. Cancer Manag Res. 2019 Feb 14;11:1517-1524. doi: 10.2147/CMAR.S176762. eCollection 2019. Cancer Manag Res. 2019. PMID: 30863161 Free PMC article.

7

Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer.

Wu W, Bai S, Zhu D, Li K, Dong W, He W, Peng S, Lai Y, Wang Q, Guo Z, Liu L, Huang H. Wu W, et al. Oncol Lett. 2019 May;17(5):4640-4646. doi: 10.3892/ol.2019.10109. Epub 2019 Mar 5. Oncol Lett. 2019. PMID: 30944653 Free PMC article.

8

The comparison of transurethral versus suprapubic catheter after robot-assisted radical prostatectomy: a systematic review and meta-analysis.

Li Z, Li K, Wu W, Wang Q, Ma X, Lin C, Peng S, Lai Y, Wang F, Huang H. Li Z, et al. Among authors: wu w. Transl Androl Urol. 2019 Oct;8(5):476-488. doi: 10.21037/tau.2019.08.25. Transl Androl Urol. 2019. PMID: 31807425 Free PMC article.

9

Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods.

Li K, Li Z, Tao Y, Wang Q, Lai Y, Wu W, Peng S, Guo Z, Huang H. Li K, et al. Among authors: wu w. Future Med Chem. 2019 Dec;11(24):3125-3137. doi: 10.4155/fmc-2019-0223. Future Med Chem. 2019. PMID: 31838901

10

Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway.

Li K, Peng S, Li Z, Lai Y, Wang Q, Tao Y, Wu W, Zhou Q, Gao Z, Chen J, Li H, Cai W, Guo Z, Huang H. Li K, et al. Among authors: wu w. Aging (Albany NY). 2020 May 27;12(10):9948-9958. doi: 10.18632/aging.103260. Epub 2020 May 27. Aging (Albany NY). 2020. PMID: 32459662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,633 results

Search Page

Filters